# RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rgd-peptide-modified-paclitaxel-prodrug-based-dual-drugs-loaded-and-redox/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Guowen Wang,Zuyi Wang,Chuankui Li,Guixin Duan,Kangwu Wang,Qicai Li,Tao Tao |
| Citations | 124 |
| DOI | 10.1016/j.biopha.2018.06.137 |
| Fields | Biochemistry, Genetics and Molecular Biology,Engineering,Materials Science |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2810069728 |
| PMID | 29966971 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Guowen Wang](https://scholariq.org/researchers/guowen-wang/)

## Paper journal

- [Biomedicine & Pharmacotherapy](https://scholariq.org/journals/biomedicine-and-pharmacotherapy/)

## Paper primary topic

- [RNA Interference and Gene Delivery](https://scholariq.org/topics/rna-interference-and-gene-delivery/)

## Paper topics

- [RNA Interference and Gene Delivery](https://scholariq.org/topics/rna-interference-and-gene-delivery/)
- [Nanoplatforms for cancer theranostics](https://scholariq.org/topics/nanoplatforms-for-cancer-theranostics/)
- [Nanoparticle-Based Drug Delivery](https://scholariq.org/topics/nanoparticle-based-drug-delivery/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.